Kirk's Market Thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts

COHR 154.52

-3.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Investor2 who wrote (9474)	4/26/2020 1:26:21 PM
From: Kirk ©	Read Replies (3) of 26443

Hopefully these anecdotal treatments can get quick, scientific studies done to help save lives and get people back working again. From what I understand, one or more of the studies using Hydroxycholoquine was terminated because too many who got the drug died or had significant side effects such as heart arrhythmia. If they can design the studies to eliminate patients with those issues, then it could be a big help. dicardiology.com It sounds like too that it is best to treat patients early before the virus does serious damage to vital organs where MDs have to find what treatment to fix the different damage while also looking at how to rid the body of the virus.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next